Tomalka, Jeffrey Alan
Pelletier, Adam Nicolas
Fourati, Slim http://orcid.org/0000-0001-6609-7587
Latif, Muhammad Bilal
Sharma, Ashish
Furr, Kathryn
Carlson, Kevin
Lifton, Michelle http://orcid.org/0000-0003-0279-2198
Gonzalez, Ana
Wilkinson, Peter
Franchini, Genoveffa http://orcid.org/0000-0003-2851-6589
Parks, Robert
Letvin, Norman
Yates, Nicole
Seaton, Kelly http://orcid.org/0000-0002-2009-3270
Tomaras, Georgia
Tartaglia, Jim
Robb, Merlin L. http://orcid.org/0000-0003-3949-9649
Michael, Nelson L.
Koup, Richard
Haynes, Barton
Santra, Sampa http://orcid.org/0000-0002-8796-1714
Sekaly, Rafick Pierre
Funding for this research was provided by:
Foundation for the National Institutes of Health (OPP1032325, OPP1032325)
U.S. Department of Health & Human Services | NIH | Office of Extramural Research, National Institutes of Health (AI067854, AI100645, AI144371)
U.S. Department of Health & Human Services | National Institutes of Health (AI060354)
Article History
Received: 22 May 2020
Accepted: 30 July 2021
First Online: 23 September 2021
Competing interests
: J.T. is an employee of Sanofi-Pasteur and provided the ALVAC vaccine components for all NHP and human studies. The other authors declare no competing interests.
Free to read: This content has been made available to all.